Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: First RMAT Approval On The Horizon; Big Weeks For Merck, Lilly And Celgene

Keeping Track Feature image

Related Content

Genentech bags first approval of breakthrough-designated drug in US

Nov 05 2013

Celgene Joins Troubled MS Club With Refuse To File For Ozanimod From US FDA

Feb 28 2018

US FDA Needs More Time To Review Clinuvel’s Scenesse For Phototoxicity

Jun 03 2019

BIO 2019 Notebook: Merck; RMAT; Out-Licensing Deals

Jun 04 2019

Keeping Track: Industry Channels Inner Gottlieb As Commissioner Departs US FDA

Apr 06 2019

Keeping Track: Approval Of First Intranasal Naloxone Copycat Highlights Otherwise Generic Week

Apr 19 2019

Woodcock, Califf Give Thumbs Up To Certain 21<sup>st</sup> Century Cures Provisions

Dec 15 2016

Keeping Track: US FDA Expands Indications For Roche Tecentriq, Lucentis, Approves Second Infliximab Biosimilar

Apr 24 2017

Can Lilly’s Cluster Headache Data Differentiate Its CGRP Inhibitor?

May 15 2018

Dupixent Approved For Severe Asthma With Broader Label Than Other Biologics

Oct 21 2018

Celgene's Positive Ozanimod Data Puts Focus On MS Commercialization

May 22 2017

'Totality Of Data' Make A Case For Luspatercept In Beta-Thalassemia, MDS

Dec 03 2018

Alnylam Will Seek Early Approval, But Givosiran Likely To Reach Market Later

Sep 27 2018

Celgene Shares Good News On Ozanimod, Quietly Dumps Pricey GED-0301

May 06 2018

Severe Asthma Market Snapshot: A Competitive Therapy Area That Will Test Payers' Influence

May 23 2018

Bristol Values Celgene's Hematology, Immunology Portfolio At $74bn, But Does It Price In Risk?

Jan 04 2019

Alnylam Ramps Up Commercial Planning For Givosiran Based On Phase III Data

Mar 06 2019

Merck And The 'Strange Business' Of Antibiotics

May 17 2019

Related Companies

Enzyvant Therapeutics, Inc.

Genentech, Inc.

Merck & Co., Inc.

Eli Lilly and Company

Boehringer Ingelheim GmbH

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Biogen, Inc.

Acceleron Pharma, Inc.

Alnylam Pharmaceuticals Inc.

Aquestive Therapeutics, Inc.

GSK plc

AstraZeneca PLC

Regeneron Pharmaceuticals, Inc.

Novartis AG

Additional Topics

United States Drug Review Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window